Bruker Corporation (BRKR)
Upgrades & Downgrades
Latest BRKR news
Bruker (BRKR) Advances Novel 4D-Proteomics Capabilities
19 September 2023
Bruker's (BRKR) commitment to innovation and customer support makes it a great partner and helps achieve its mission of translating nature into medicine.
Bruker (BRKR) Inks Fraport Framework Contract for ETD Systems
12 September 2023
Bruker's (BRKR) DE-tector flex system uses a non-radioactive ionization source and is approved by national regulatory bodies and ECAC.
Here's Why You Should Retain Bruker (BRKR) Stock for Now
8 September 2023
Investors continue to be optimistic about Bruker (BRKR), backed by the performance of the CALID and NANO groups and strength in acquisitions.
Bruker Corporation to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
24 August 2023
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 21st annual Morgan Stanley Global Healthcare Conference in New York City...
Bruker (BRKR) Set to Acquire PhenomeX in an All-Cash Deal
18 August 2023
Bruker (BRKR) initiates its entry into since-cell biology research solutions with the acquisition of PhenomeX.
PhenomeX stock rallies by 137% after buyout offer from Bruker
17 August 2023
PhenomeX Inc. CELL, +137.43% stock has more than doubled on Thursday after Bruker Corp. BRKR, -2.56% said it would acquire the Emeryville, Calif.-based, cell biology company for $1 a share in a deal t...
Bruker (BRKR) Q2 Earnings and Revenues Top, '23 Sales View Up
4 August 2023
Bruker (BRKR) delivers better-than-expected earnings and revenues in the second quarter of 2023.
Bruker Corporation (BRKR) Q2 2023 Earnings Call Transcript
3 August 2023
Bruker Corporation (NASDAQ:BRKR ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Justin Ward - Senior Director of IR & Corporate Development Frank H. Laukien - Chairma...
Bruker (BRKR) Surpasses Q2 Earnings and Revenue Estimates
3 August 2023
Bruker (BRKR) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.45 per share a year ago.